Skip to main content

Spin-offs

IRB Barcelona aims to stimulate an entrepreneurial spirit among its researchers, thus facilitating technology transfer and promoting the creation of spin-offs. Since it was founded, the Institute has generated 6 spin-off companies, of which 5 are currently active. Altogether, the spin-offs have raised over 60M EUR.

Gate2Brain was founded in 2020 as a result of research devoted to peptides with the capacity to cross the Blood-Brain Barrier (BBB) and…

Ona Therapeutics was launched in 2019 and is specialised in the discovery and development of therapeutic biologics targeting tumour metastasis-…

Nostrum Biodiscovery is a biotech company that was founded in 2015.

Inbiomotion is a Barcelona-based company dedicated to personalised medicine that was set up in 2011.

Accure Therapeutics was created in 2020 to boost two existing companies in CNS.

Omnia Molecular was launched in 2006 and suspended activity in 2016.